Health Care & Life Sciences » Healthcare Provision | GrowBlox Sciences Inc.

GrowBlox Sciences Inc. | Income Statement

Fiscal year is April-March. All values USD Thousands.
2014
2015
2016
2017
2018
Sales/Revenue
-
-
-
-
2,510.40
Cost of Goods Sold (COGS) incl. D&A
0.10
70.00
177.10
416.00
1,185.10
Gross Income
0.10
70.00
177.10
416.00
1,325.20
SG&A Expense
187.60
7,903.80
6,781.60
8,517.10
19,149.90
EBIT
187.80
7,973.90
6,958.80
8,933.10
17,824.70
Unusual Expense
415.40
-
-
-
-
Non Operating Income/Expense
-
0.40
15.00
248.90
158.20
Interest Expense
52.80
0.20
105.20
901.10
5,176.40
Pretax Income
656.00
7,973.70
7,079.00
10,083.10
23,159.20
Consolidated Net Income
656.00
7,973.70
7,079.00
10,083.10
23,159.20
Net Income
656.00
7,722.80
6,771.30
9,909.80
22,974.20
Net Income After Extraordinaries
656.00
7,722.80
6,771.30
9,909.80
22,974.20
Net Income Available to Common
656.00
7,722.80
6,771.30
9,909.80
22,974.20
EPS (Basic)
0.70
0.26
0.15
0.13
0.17
Basic Shares Outstanding
940.70
29,520.30
44,911.50
79,002.70
132,934.10
EPS (Diluted)
0.70
0.26
0.15
0.13
0.17
Diluted Shares Outstanding
940.70
29,520.30
44,911.50
79,002.70
132,934.10
EBITDA
187.60
7,903.80
6,781.70
8,517.10
17,019.90
Minority Interest Expense
-
251.00
307.60
173.30
185.00

About GrowBlox Sciences

View Profile
Address
3550 West Teco Avenue
Las Vegas Nevada 89118
United States
Employees -
Website http://www.gbsciences.com
Updated 07/08/2019
GB Sciences, Inc. is a technology and solution company, which engages in the biopharmaceutical research and development of cannabis plant into medicines, therapies, and treatments. It aims to develop standardized, pharmaceutical-grade, cannabinoid therapies that target a variety of medical conditions. The company was founded on April 4, 2001 and is headquartered in Las Vegas, NV.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.